SI-BONE Inc SIBN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $13.85
- Day Range
- $13.91–14.70
- 52-Week Range
- $11.76–22.56
- Bid/Ask
- $14.42 / $17.50
- Market Cap
- $612.07 Mil
- Volume/Avg
- 419,623 / 341,573
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.97
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 0.08%
Company Profile
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 344
- Website
- https://www.si-bone.com
Comparables
Valuation
|
Metric
|
SIBN
|
AORT
|
ZIMV
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 101.58 | 45.82 |
Price/Book Value | 3.70 | 3.74 | 1.12 |
Price/Sales | 3.97 | 2.92 | 0.98 |
Price/Cash Flow | — | 23.04 | 49.02 |
Price/Earnings
SIBN
AORT
ZIMV
Financial Strength
|
Metric
|
SIBN
|
AORT
|
ZIMV
|
|---|---|---|---|
Quick Ratio | 7.99 | 2.65 | 1.06 |
Current Ratio | 9.17 | 5.63 | 1.94 |
Interest Coverage | −12.97 | 0.96 | 0.07 |
Quick Ratio
SIBN
AORT
ZIMV
Profitability
|
Metric
|
SIBN
|
AORT
|
ZIMV
|
|---|---|---|---|
Return on Assets (Normalized) | −6.03% | 1.39% | 0.60% |
Return on Equity (Normalized) | −8.10% | 3.82% | 1.42% |
Return on Invested Capital (Normalized) | −8.97% | 5.06% | 1.51% |
Return on Assets
SIBN
AORT
ZIMV
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Jrjcgwcsl | Cknjpd | $196.0 Bil | |||
| Stryker Corp
SYK
| Qjnlzsmvt | Sfbv | $133.8 Bil | |||
| Boston Scientific Corp
BSX
| Frcmyrm | Bkkyrfg | $124.5 Bil | |||
| Medtronic PLC
MDT
| Vxtvpwq | Cvclz | $113.2 Bil | |||
| Edwards Lifesciences Corp
EW
| Fgbgqjyc | Qckcsmn | $39.5 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Bhwmf | Nbwt | $30.2 Bil | |||
| DexCom Inc
DXCM
| Blwcnbjmb | Vdmqh | $27.3 Bil | |||
| Steris PLC
STE
| Ssczkzjmr | Sbmscm | $22.8 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Gyrkhrjc | Rjfm | $21.3 Bil | |||
| Insulet Corp
PODD
| Cwxmzkzr | Wlqts | $16.1 Bil |
United States